| Product NDC: | 58394-004 |
| Proprietary Name: | Neumega |
| Non Proprietary Name: | oprelvekin |
| Active Ingredient(s): | & nbsp; oprelvekin |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58394-004 |
| Labeler Name: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103694 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19971101 |
| Package NDC: | 58394-004-08 |
| Package Description: | 10 CARTON in 1 TRAY (58394-004-08) > 1 KIT in 1 CARTON * 5 mL in 1 VIAL, SINGLE-DOSE (58394-104-08) * 1 mL in 1 SYRINGE (58394-019-02) |
| NDC Code | 58394-004-08 |
| Proprietary Name | Neumega |
| Package Description | 10 CARTON in 1 TRAY (58394-004-08) > 1 KIT in 1 CARTON * 5 mL in 1 VIAL, SINGLE-DOSE (58394-104-08) * 1 mL in 1 SYRINGE (58394-019-02) |
| Product NDC | 58394-004 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oprelvekin |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19971101 |
| Marketing Category Name | BLA |
| Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |